These final results, along with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 aid the idea of focusing on ACKR3 as a unique strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-connected Diseases. In addition to the https://algirdase394dvq2.wikilima.com/user